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Sensitive detection 
of Plasmodium vivax malaria 
by the rotating‑crystal 
magneto‑optical method 
in Thailand
Ágnes Orbán1*, Rhea J. Longley2,3,4, Piyarat Sripoorote3, Nongnuj Maneechai3, 
Wang Nguitragool5, Ádám Butykai1, Ivo Mueller2,4,6, Jetsumon Sattabongkot3, 
Stephan Karl7,8 & István Kézsmárki1,9
The rotating‑crystal magneto‑optical detection (RMOD) method has been developed for the rapid and 
quantitative diagnosis of malaria and tested systematically on various malaria infection models. Very 
recently, an extended field trial in a high‑transmission region of Papua New Guinea demonstrated 
its great potential for detecting malaria infections, in particular Plasmodium vivax. In the present 
small‑scale field test, carried out in a low‑transmission area of Thailand, RMOD confirmed malaria 
in all samples found to be infected with Plasmodium vivax by microscopy, our reference method. 
Moreover, the magneto‑optical signal for this sample set was typically 1–3 orders of magnitude higher 
than the cut‑off value of RMOD determined on uninfected samples. Based on the serial dilution of the 
original patient samples, we expect that the method can detect Plasmodium vivax malaria in blood 
samples with parasite densities as low as ∼5–10 parasites per microliter, a limit around the pyrogenic 
threshold of the infection. In addition, by investigating the correlation between the magnitude of the 
magneto‑optical signal, the parasite density and the erythrocytic stage distribution, we estimate the 
relative hemozoin production rates of the ring and the trophozoite stages of in vivo Plasmodium vivax 
infections.
Although humanity is continuously facing novel medical challenges, the management of preventable infectious 
diseases, which place heavy burden on tropical countries, has been a long-sought goal of the  WHO1. One such 
disease is malaria, and by virtue of increased global and local efforts significant progress has been made towards 
its control worldwide. Since many countries are working towards the substantial reduction of disease burden, 
the development of sensitive, rapid, high-throughput and low-cost malaria diagnostic methods applicable for 
mass-screening is a pressing issue in tropical diseases  research2.
One promising diagnostic approach is the utilisation of the magnetic properties of Plasmodium-infected 
red blood cells, as it may enable the rapid and quantitative detection of the infection at low  cost3–7. During the 
intraerythrocytic cycle the parasites break down the hemoglobin of their host cell and sequester its iron con-
tent into the inert, submicron-sized paramagnetic hemozoin crystals, which are distinguishing features of all 
blood-stage Plasmodium  infections8,9. In the recent years, our research group has developed a new technique, 
the rotating-crystal magneto-optical diagnostic detection (RMOD) method, which is capable of the quantitative 
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detection of malaria by measuring the amount of hemozoin produced during the course of the infection. The 
diagnostic capability of RMOD was tested in several steps using synthetic β-hematin crystals, P. falciparum cell 
cultures and mouse  infections10–13. Furthermore, it proved to be an efficient tool for conducting rapid, yet sensi-
tive drug susceptibility  assays14.
Recently, a detailed evaluation of RMOD has been carried out in an extended field trial in Papua New 
Guinea (PNG) involving almost one thousand malaria-suspected patients and multiple reference  methods15. One 
important—and anticipated—observation of the study was that infections with different species led to different 
average blood hemozoin levels, resulting in a more sensitive detection of P. vivax than P. falciparum. However, 
the presence of stage V P. falciparum gametocytes increased the likelihood of identifying P. falciparum infections 
due to their high hemozoin content. As another key finding, the mean value and the standard deviation of the 
magneto-optical (MO) signal for samples which tested negative with all reference methods was significantly 
higher than expected from previous RMOD measurements on malaria-naïve blood  samples11,12. Accordingly, we 
concluded that in high-transmission settings, such as the study site in PNG, elevated hemozoin levels are likely 
to be maintained in the peripheral blood of a large proportion of the general population, either from concurrent 
low-level infections that are otherwise undetectable, or from previously resolved  infections16,17.
In order to further investigate these observations and to assess the sensitivity of RMOD for diagnosing P. vivax 
infections in low-transmission settings, here we use the technique to detect malaria in samples confirmed to be 
P. vivax-positive by microscopy from Thailand, a country with overall low malaria  endemicity18,19. In addition 
to testing the sensitivity of the method, we evaluate the correlation between the magnitude of the MO signal and 
the parasite stage distributions of the samples.
The potential of the magneto-optical approach for diagnosing malaria has also been demonstrated in a recent 
field test by another hemozoin-based tool, Gazelle, which showed a sensitivity of 96.2% for the detection of P.vivax 
 infections20. The main difference between RMOD and Gazelle is that the former detects the periodic modula-
tion of light transmission induced by the hemozoin crystals co-rotating with a rotating magnetic field, while the 
latter measures light transmission in stationary states with and without a static magnetic field. In spite of this 
technical difference, the physical principle of detection is common. Thus, the magneto-optical quantification of 
hemozoin should support not only a qualitative, but a quantitative diagnosis in both cases. While this capability 
has not been investigated for Gazelle, it is an important objective of the present study.
Results
The sensitivity of RMOD in detecting P. vivax infections. The parasite densities of the original 35 
patient samples ranged from 34µl−1 to 5142µl−1 with a median of 875µl−1 . As seen in Fig. 1A, this range was 
well covered by the samples, though their parasite density distribution was not uniform.
Besides the overall parasite density, the erythrocytic stage distribution was also determined by an expert 
microscopist, and the parasites were classified as rings, trophozoites, schizonts, male and female gametocytes. The 
latter three forms contributed less than 10% to the overall parasite density in all samples with one exception, in 
which their proportion reached 35%. The sequestration of schizonts is a well-known phenomenon in P. falcipa-
rum infections, but the statistics of our P. vivax samples suggests that it also occurs for P. vivax21. Accordingly, the 
blood smears exhibited mostly rings and trophozoites, but their relative ratios varied in the sample population. A 
large fraction of samples (n=27) showed a relatively synchronous character and contained either predominantly 


































Figure 1.  (A) The parasite density values of the P. vivax-infected samples (n = 35) with their median and 
the 95% confidence interval (95%-CI) of the median. (B) The percentage of samples containing the indicated 
proportion of rings (light grey columns) and trophozoites (dark grey columns), i.e., histograms of the incidence 
rate of rings and trophozoites.
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peripheral circulation of P. falciparum infections, in the case of these P. vivax-positive samples more than 30% 
of the samples showed no ring forms, and 88% contained trophozoites in more than 10%.
As a first step, the level of the weak residual MO signal, that is present even in samples of malaria-naïve 
individuals, was measured on a pool of uninfected samples in order to establish a threshold that separates 
malaria-positive and negative RMOD incidences. Measurements on fourteen uninfected samples obtained from 
malaria-naïve individuals in Thailand, each measured in duplicates, yielded an average residual MO value of 
(0.50± 0.22)mV/V as presented in Fig. 2A. The MO signal level that separates malaria-positive and -negative 
incidences, i.e., the cut-off level, was determined as the mean plus two times the standard deviation of these 
residual values, assuming that the MO values of uninfected samples are normally distributed random variables. 
This led to a cut-off level of 0.94 mV/V as indicated by the horizontal black dotted line in Fig. 2B and C.
As displayed in Fig. 2B, all the P. vivax-infected blood samples tested above the cut-off, yielding a 100% 
sensitivity on this sample set. Moreover, for more than 90% of the samples the MO values are at least one order 
of magnitude larger than the cut-off, implying that the method can detect lower parasite densities. To model 
such cases, we chose ten of the original blood samples and prepared dilution series from them using uninfected 
whole blood as dilution medium. The parasite densities of the original ten samples change between 34µl−1 and 
4980µl−1 , while the parasite densities of the most diluted samples cover the range of 0.0003− 9µl−1.
The MO values of the diluted samples prepared from the same infected specimen (identically coloured 
circles in Fig. 2B) decrease linearly with increasing dilution over several orders of magnitude as their parasite 
densities decrease proportionally with the dilution. However, the MO values of highly diluted samples with 
very low parasite densities (< 1µl−1) are independent of the nominal parasite load. These residual MO val-
ues are scattered around the mean residual value obtained for the uninfected controls, below the cut-off level 
defined previously. This further supports that this residual MO signal is unrelated to parasites. Accordingly, 
the limit of detection in terms of parasite density is defined as the average parasite density for samples with 
MO values near the cut-off, i.e., in the range of 0.94± 0.08mV/V . This estimate leads to a detection limit of 
approx. 5µl−1 (range: 0.2− 12 µl−1) as indicated by the black arrow (line segment) in Fig. 2B. For comparison, 
this sensitivity threshold is somewhat better than the threshold reported in the recent field test of the Gazelle 
device, where the parasite density of false negative cases was reported to range from 18 to 174µl−1 , when optical 
microscopy was used as a  reference20.
The correlation between the MO values, the parasite density and the stage distribution. As 
observed in Fig. 2, the relationship between the parasite densities and the corresponding MO values is linear 
(Spearman Rank: R ≥ 0.95, p < 0.0001 ) for samples obtained by serial dilution as long as their MO values are 






































Figure 2.  (A) The MO values of fourteen malaria-naïve samples obtained from two individuals at various time-
points during the course of the study with their mean and standard deviation. (B) The MO values of the infected 
samples (grey circles, n=35) plotted as the function of their parasite densities. Each data point represents the 
average MO value of at least two technical duplicates (individual errors are below 10% and obscured by the 
logarithmic scale). The coloured symbols show the MO values of samples obtained by serial dilution of ten 
infected samples. The black continuous and dashed lines indicate the mean MO value of the malaria-naïve 
samples and the cut-off level, respectively, while the black arrow marks the estimated lowest detectable parasite 
density by RMOD. (C) The blue asterisks show the MO values of P. vivax-infected samples collected in Papua 
New Guinea (n = 104), as reproduced from Ref.15. The blue dashed line marks the cut-off value for RMOD 
determined by receiver operating characteristic (ROC) analysis in that  study15.
4
Vol:.(1234567890)
Scientific Reports |        (2021) 11:18547  | https://doi.org/10.1038/s41598-021-97532-9
www.nature.com/scientificreports/
(undiluted) samples is R = 0.66 (Spearman rank, 95%-CI : 0.40 to 0.81) indicating only a moderate correlation. 
This scattering of the MO values for samples with nearly the same parasitemia naturally arises, at least in part, 
from the fact that RMOD quantifies the amount of hemozoin in blood, which depends not only on the overall 
parasite density, but also on the stage distribution of the circulating parasites and the clearance rate of hemozoin 
from the circulation. This scattering of the MO values due to the listed factors also explains the relatively large 
error of the detection limit specified above.
While the MO signal shows only a moderate correlation with the parasite density, it correlates better with the 
estimated hemozoin content (HZ), which is a parameter calculated by assuming different hemozoin production 
rates of the different erythrocytic stages. When we use a subset of samples with clear dominance of rings and 
trophozoites, i.e., that contain schizonts and gametocytes in less than 3% , the hemozoin content is well approxi-
mated by HZ = 1 · Ri + α · T , where Ri and T denote the density of rings and trophozoites, respectively, and 
α is the relative hemozoin contribution of trophozoites compared to rings. (Please note that HZ parameter is a 
weighted parasite density, which is not equal to the actual hemozoin concentration, but is linearly proportional to 
it.) As shown in Fig. 3A, the Spearman correlation coefficient between the MO values and the corresponding HZ 
values reaches its maximum, R = 0.9 , at α = 4.5± 0.3 . Although the assessment of the relative production rate 
for schizonts and gametocytes is less accurate due to their rare occurrence and the limited statistical sample size, 
their contribution is estimated to be approx. 12–20 times higher than the hemozoin content of rings. As presented 
in Fig. 3B, for the full sample set the best Spearman correlation, R = 0.75 (95%-CI : 0.55 to 0.87) , was achieved 
with the following relative hemozoin contributions of the different stages: HZ = 1 · Ri + 4.5 · T + 17 · (S + G) , 
where S and G denote the density of schizonts and gametocytes in the samples, respectively.
Discussion
The RMOD was able to classify all P. vivax-infected samples as malaria-positive with MO values typically 1–3 
orders of magnitude higher than the cut-off level determined using samples of malaria-naïve volunteers. Further-
more, by preparing serial dilutions from the original patient samples, we found that parasite densities as low as 
a few parasites per a microliter of blood are still detectable by RMOD. These results indicate that the estimated 
limit of detection of RMOD is poorer than that of the most sensitive molecular diagnostic tools such as real-
time PCR, PCR and loop mediated isothermal amplification—all of which show a detection limit in the range 
of ≤ 1− 10µl−1 , but dependent on the blood volume subjected to the  assay22. However, the limit of detection 
for P. vivax found in this study for RMOD competes with that of the current clinical diagnostic tools, i.e., light 
microscopy with a limit of detection of ∼ 50− 500µl−1 and antigen-based rapid diagnostic tests with a limit 
of detection of ∼ 200µl−122. It has to be noted, however, that the limit of detection for RMOD could only be 
determined on serial dilutions of certain infected samples in lack of original samples with very low parasitemias, 
and the number of samples used in the current study was limited.
In our previously conducted large-scale field trial in Papua New Guinea, where expert light microscopy was 
used as the main reference method, the median MO value of the samples obtained from suspected patients 
whose light microscopy results were negative, was found to be 1.68mV/V (IQR: 1.06− 2.89mV/V))15. 
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Figure 3.  (A) The Spearman rank correlation coefficient between the MO values and the estimated hemozoin 
content, HZ = 1 · Ri + α · T , as the function of α . The red curve shows the correlation coefficient calculated for 
the subset of samples in which the proportion of schizonts and gametocytes was below 3% (n = 19). The black 
curve shows the correlation coefficient for the full sample set (n = 35). (B) The MO values as the function of 
parasite density (bottom x-axis, blue circles) and as the function of HZ (top x-axis, red diamonds).The latter was 
calculated using the value α = 4.5 (determined from the red curve in panel A), and also including the hemozoin 
contributions from schizonts and gametocytes, as described in the main text. The Spearman rank correlation 
coefficients for the two cases are also indicated.
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This value is significantly higher than the mean MO value of the control samples in the current Thai study: 
0.55mV/V (IQR: 0.36− 0.89mV/V) ). The most plausible hypothesis to explain this observation is that a con-
siderable portion of the patients at PNG, a high-transmission location, has residual hemozoin in the peripheral 
blood either due to low-density asymptomatic infections, or due to hemozoin crystals remaining in the circula-
tion after recently treated or cleared infections. This factor increased the MO cut-off level in the PNG study and, 
thus, seemingly compromised the diagnostic performance.
To further elaborate on this, we make a direct comparison between the field samples from Thailand and 
PNG in Fig. 2C where we present the MO values for all light microscopy-positive P. vivax samples collected in 
PNG (data reproduced  from15). This comparison reveals that the Thai and PNG data sets follow the same trend 
and the magnitude of the MO values in the two studies spans the same range. Most importantly, for 98% of the 
samples found P. vivax-positive in the PNG study the MO values are located above 0.94 mV/V, the cut-off level 
determined in the current study. This supports the assumption that a considerable fraction of false-positive MO 
detections in the PNG study are due to the high residual hemozoin level present in the population at high trans-
mission settings. Whether these are ongoing asymptomatic infections or recently resolved ones is yet unclear. In 
a recent study Kho and co-workers found large biomass of intact asexual-stage malaria parasites in the spleen of 
asymptomatic and microscopy-negative malaria  patients23. If some of the hemozoin produced by these otherwise 
undetected parasites can re-enter the peripheral circulation, it could be the source of the unexpectedly high MO 
signals in some of the microscopy-negative cases in our PNG study. However, to confirm this hypothesis further 
large-scale studies are crucial both in high- and low-transmission and/or elimination settings. Accordingly, for 
RMOD or any other hemozoin-based malaria detection method, the final field of application, e.g., as an in-
field diagnostic device, epidemiological surveillance tool, can only be determined after elucidating the former 
issue. From a technological point of view, they have the benefits of requiring only minimal sample preparation, 
practically no expertise for operation and have the potential to be realised in a cost-efficient, field-applicable 
format. On the other hand, whether RMOD operation can be extended to facilitate species-specific diagnosis 
at least on the level of the current rapid diagnostic tests, is still the subject of our investigations. Furthermore, 
for its applicability in epidemiological surveillance studies, as a pre-screening tool for example, an increase in 
throughput of the current design is needed.
RMOD quantifies the concentration of hemozoin in the peripheral blood which can be present within the 
parasites, erythrocytes or leukocytes at the time of sampling. Since a coarse categorisation of the erythrocytic 
stages was carried out and the densities of the different stages were determined by expert microscopy, the 
hemozoin production rates of the different stages could be estimated based on the MO values of the samples. We 
found that trophozoites in these in vivo P. vivax samples contain approx. 4.5 times more hemozoin than rings, 
while older stages (schizonts and gametocytes) contain 12–20 times larger amounts than rings. These values are 
comparable to the relative hemozoin production rates of rings, trophozoites and schizonts reported previously 
for P. falciparum cell  cultures14,24,25. From this we conclude that the actual hemozoin content in peripheral blood 
primarily reflects the momentary hemozoin production rate, i.e., a dynamic equilibrium is maintained between 
hemozoin production and clearance, as also observed in rodent  infections12,13. However, since RMOD could also 
confirm the infection in samples containing exclusively ring stages, whose hemozoin content is much lower than 
the hemozoin content of trophozoites and schizonts, a non-negligible hemozoin accumulation also has to occur 
in the peripheral blood during acute infections. Likely this is the reason why P. falciparum infections—which 
exhibit primarily very young stages in the circulation—could be diagnosed by RMOD in PNG as well, however 
with a lower sensitivity than P. vivax15.
The most important requirements towards a novel method for in-field malaria diagnostics are the ease of 
use and high sensitivity – ideally even the detection of asymptomatic infections. However, besides the highly 
reliable differentiation between positive and negative cases, the quantitative assessment of disease severity might 
provide crucial information in certain clinical situations. In clinical practice today the parasite density is used 
as the primary characteristics of acute malaria infections, however, the proportion of hemozoin-containing 
white blood cells has also been investigated as a potential indicator of  prognosis17,26–28. The relation between 
the intraleukocytic hemozoin content and disease severity reported in former studies implies that the overall 
hemozoin concentration in the peripheral circulation may also serve as a useful clinical  indicator17,26. The quan-
titative nature of RMOD, realising a hemozoin-based diagnosis, can also be highly advantageous in this respect.
Materials and methods
Sample collection and characterisation in Thailand. Sample collection was carried out in two field-
clinics in the Kanchanaburi and Ratchaburi provinces of western Thailand from May 2014 to June 2015 (n =33), 
while two additional infected samples were obtained in July, 2016. Patients attending to the clinics exhibiting 
symptoms consistent with malaria were tested for the infection using an SD Bioline Malaria Ag P.f/Pan rapid 
diagnosis test kit (Standard Diagnostics Inc.) and/or via light microscopic (LM) examination of thick blood 
smears. Once a positive diagnosis was established, a blood sample of approximately 250 µl was collected into 
an EDTA-containing Microtainer (Becton Dickinson and Company) via venipuncture from consented volun-
teers. The blood aliquots were subsequently frozen and transported over dry ice to the Mahidol Vivax Research 
Unit (MVRU) of Mahidol University, Bangkok, where they were stored at −70◦ until the completion of the 
RMOD measurements.
Approximately 40 uninfected blood samples were collected from two consented, malaria-naïve colleagues 
on-site at various time points over the study period for protocol optimisation and for the establishment of an 
uninfected baseline signal for the RMOD. These control samples were collected, frozen and stored the same way 
as the infected samples. Seven samples from both individuals were utilised to determine the uninfected baseline 
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signal and the cut-off level of the study (see Fig. 2A) while the rest of the samples were used to prepare dilution 
series from ten infected samples (see Fig. 2B).
As a reference method for the RMOD study, a good-quality, Giemsa-stained thick blood smear was prepared 
from all P. vivax-infected samples on site, and analysed later by an expert microscopist at the central laboratory of 
MVRU, Bangkok. The morphological analysis of the parasites confirmed that all samples were infected exclusively 
with P. vivax. The thick blood smears were prepared using exactly one microliter of blood, thus by counting all 
the parasites in the total area of the smears ( ×1000 magnification) the parasite density was therefore determined 
directly. Furthermore, the parasites detected in the smears were assigned to stage groups (rings, trophozoites, 
schizonts, male gametocytes and female gametocytes) according to their morphology.
Sample collection and characterisation in PNG. The sample collection was carried out at two health 
facilities in Madang, located on the north coast of Papua New Guinea where P. falciparum and P. vivax are 
highly  endemic29. During the period of November, 2017-July, 2018 n = 945 blood samples were collected from 
suspected malaria patients and analysed by RMOD and multiple control methods, out of which n = 104 were 
found to be P. vivax monoinfections using LM as reference. Two blood slides for LM were prepared at enrolment 
and the LM analysis was carried out by the PNG Institute of Medical Research microscopy unit consisting of 
experienced, WHO-certified microscopists.
Thick blood smears were examined independently by two microscopists, for 200 thick-film fields ( ×1000 
magnification) before being declared Plasmodium-negative. Parasite density was calculated from the number of 
parasites per 200-500 leukocytes (depending on parasite density) and an assumed leukocyte density of 8000µl−1
30. Slides were scored as LM-positive for an individual Plasmodium species if the species was detected indepen-
dently by at least two microscopists.
Ethics statements. The study conducted in Thailand received ethical clearance from the Ethics Committee 
at the Faculty of Tropical Medicine, Mahidol University (MUTM 2013-027-01). The study was clearly explained 
to all volunteers and informed consent was obtained from all participants in the study.
The study conducted in Papua New Guinea received ethical clearance by the PNG Institute of Medical 
Research (PNGIMR) Institutional Review Board and the PNG Medical Research Advisory Committee (MRAC, 
#16.45). All methods were carried out in accordance with the relevant guidelines and regulations of the named 
institutes.
Magneto‑optical measurements. The concept of the rotating-crystal magneto-optical setup and the 
underlying physical principles of hemozoin detection are described in detail in our former  studies10,15,31. Briefly, 
the liquid sample containing the elongated paramagnetic hemozoin crystals is inserted into the centre of a ring-
shaped assembly of permanent magnets, which creates a strong uniform magnetic field at the sample position. 
When the magnetic ring is rotated, the crystals follow this rotation which modulates the intensity of the light 
passing through the sample. The modulated intensity divided by the average intensity, which has been shown to 
be linearly proportional to the crystal concentration, corresponds to the measure MO values’ displayed in the 
corresponding figures in mV/V  units10.
For the RMOD analysis in Thailand, the frozen blood samples were thawed on room temperature, mixed 
thoroughly and 35µl of the partially lysed blood was mixed with 315µl of lysis solution (13 mM of NaOH 
and 0.03% (v/v) of Triton X-100 in distilled water) and allowed to stand for approximately 5 minutes to ensure 
complete lysis and homogenisation. Thereafter, 280µl of the lysate, hereinafter referred to as optical sample, was 
transferred into the optical sample holders and the RMOD measurements were performed without further delay. 
Optical samples for RMOD measurements were prepared in duplicate per blood sample.
For the estimation of the RMOD sensitivity threshold two- or four-fold dilution series were prepared from 
ten infected samples. The infected samples were thawed and diluted with thawed aliquots of malaria-naïve blood 
samples frozen and stored together with the infected specimens. After the thorough mixing of the two compo-
nents the final optical samples for the RMOD measurements were prepared as described above.
The magneto-optical measurements in Thailand and PNG were carried out with two RMOD devices that 
were technical replicates using the same measurement protocols. The only differences between the two RMOD 
experiment series were that in PNG the samples were freshly hemolysed and measured in triplicates per blood 
sample, while in Thailand the whole blood samples were frozen and stored until the completion of the RMOD 
measurements and they were measured in duplicates per blood sample.
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